Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
Status:
Completed
Trial end date:
2017-09-15
Target enrollment:
Participant gender:
Summary
This is a phase IB study to assess the safety and tolerability of ASLAN001 when given in
combination with either Cisplatin and 5-Fluorouracil or Cisplatin and Capecitabine, with a
view to identifying the recommended Phase II dose.